Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Related Posts
Bitcoin RICO: Feds say $265 million crypto theft ring blew $13M on exotic cars, nightclubs
One defendant allegedly sent shipments of $25,000 in laundered currency hidden in squishmallow stuffed animals around the United States.
Stellantis delays Ram electric pickup trucks until 2025
Stellantis is delaying the launch of its Ram electric pickup trucks from this year until the first half of 2025.
Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.